# Vamsi Pharma > Tuning Life Always ## Posts - [From Concept to Commissioning: Why a Dry Powder Inhaler CDMO Accelerates Inhalation Drug Development](https://vamsipharma.com/from-concept-to-commissioning-why-a-dry-powder-inhaler-cdmo-accelerates-inhalation-drug-development/): From Concept to Commissioning: Why a Dry Powder Inhaler CDMO Accelerates Inhalation Drug Development What makes DPI development different (and harder) than oral drugs Developing an inhalation therapy is uniquely complex: particle engineering, device compatibility, aerosol performance and global regulatory demands all have to align. That’s why working with a DPI-focused CDMO — one with inhalation-specific technology and a Concept-to-Commissioning approach — can be the difference between a stalled project and a successful IND/CTA and commercial launch. At Vamsi Pharma (WHO-GMP; Telangana, India; founded 2015) we specialize in Dry Powder Inhaler (DPI) development, from premix design to device combo packs, analytical […] ## Pages - [Terms & Conditions](https://vamsipharma.com/terms-conditions/): Welcome to Vamsi Pharma Pvt. Ltd. . These Terms & Conditions  govern your access to and use of our website, services, and any content provided therein. By using this website, you agree to comply with these Terms. If you do not agree, please refrain from accessing or using our website. Use of Website The information provided on this website is for general informational purposes only and should not be considered medical advice, diagnosis, or treatment. Our products and services are intended for pharmaceutical partners, researchers, and professionals and are not directly marketed or sold to consumers for personal medical use. You […] - [DPI Pipeline](https://vamsipharma.com/dpi-pipeline/): Products Robust pipeline aligned with global respiratory needs Our DPI pipeline is built on a strong foundation of innovation, scientific rigor, and market relevance — focusing on respiratory therapies for asthma, COPD, and related conditions. Par with innovator brands: Our formulations are developed to match the performance of leading global brands, ensuring therapeutic equivalence and market readiness. In-vitro studies completed: Each product in our pipeline undergoes extensive in-vitro characterization to support quality, efficacy, and regulatory documentation. Product Table Products Sr No Product 1 Glycopyrronium + Indacaterol 2 Glycopyrronium + Formoterol 3 Fluticasone + Vilanterol 4 Budesonide + Formoterol + Glycopyrronium 5 […] - [DPI Finished Product](https://vamsipharma.com/dpi-finished-product/): Products Reliable supply of quality DPI capsules, backed by logistics validation We provide fully developed DPI finished dosage forms with and without device options, offering flexibility and scalability for diverse market demands. Customized pack sizes: Available in multiple configurations including 15, 30, and 60 capsules per bottle to suit therapy duration and market requirements. Combo packs with device: Products can be supplied as a ready-to-use combo pack with a single-use punch inhaler device, ensuring user convenience and compliance. Multilingual packaging: All FDFs can be packed with multilingual labeling to meet regional regulatory and patient needs. Braille-coded packs: We offer braille-coded packaging […] - [Bulk Capsules](https://vamsipharma.com/dpi-bulk-capsules/): Products Reliable supply of quality DPI capsules, backed by logistics validation Our bulk capsules are filled with high-quality DPI premixes and supplied in secure packaging tailored for B2B supply chains. Each shipment is backed by stability and transportation studies to ensure product integrity is maintained across varied climatic and transit conditions. - [Contact Us](https://vamsipharma.com/contact-us/): Contact Us Looking for a trusted CRO and CDMO partner or exploring DPI product sourcing? We’re ready to collaborate. Let’s Talk Inhalation! Send Request info@vamsipharma.com Business & Inquiries: +91-88302-47608 Call Us Anytime Registered Office & Factory: Sy Nos. 707 & 708, Mekaguda Village, Ranga Reddy- 509228, Telangana, India. - [DPI Premix](https://vamsipharma.com/dpi-premix/): Products Precision-engineered blends for efficient DPI capsule filling Our DPI Premix formulations are designed to streamline your manufacturing process while ensuring consistent performance and regulatory compliance. Ready-to-fill capsules: Pre-mixed API and excipient blends developed with our particle engineering expertise for optimal flow and uniformity, ensuring ease of capsule filling and dosage accuracy. Technology Transfer (TT) Services: We offer comprehensive TT support to ensure seamless integration of our premixes into your production environment.  Optimized packaging: Supplied in packaging designed for easy handling, almost no powder loss, and direct capsule filling – reducing operational complexities. - [Privacy Policy](https://vamsipharma.com/privacy-policy-4/): Who we are Vamsi Pharma (“we,” “our,” or “us”) respects your privacy and is committed to protecting the personal information you share with us. This Privacy Policy explains how we collect, use, disclose, and safeguard your information when you visit our website www.vamsipharma.com. By accessing or using our website, you agree to the practices described in this Privacy Policy. Comments We may collect the following types of information: Personal Information: Name, email address, phone number, company/organization details, job title, and any information submitted through our contact forms. Non-Personal Information: Browser type, IP address, device information, pages visited, and other analytics data […] - [Gallery](https://vamsipharma.com/gallery/): All Facility Team - [About Us](https://vamsipharma.com/about-us/): About Us Your reliable Inhalation Partner for the Long Term alliance Founded in 2015, Vamsi Pharma Pvt. Ltd. has established itself as a trusted partner in the pharmaceutical industry, specializing in the development and manufacturing of orally inhaled & nasal drug products (OINDP). Over the years, we have grown into a dual-role organization—functioning both as a Contract Research Organization (CRO) and a Contract Development and Manufacturing Organization (CDMO)—with a sharp focus on delivering inhalation therapies that improve patient outcomes across the globe. Our WHO-GMP certified facility, located in Hyderabad Telangana, India, is dedicated to advancing inhalation technology with a special emphasis […] - [Services](https://vamsipharma.com/services/): Comprehensive solutions across the inhalation product lifecycle, ensuring efficiency, quality, and regulatory compliance. Contract Manufacturing (CDMO) – Premix | Bulk Capsules | FDF (With/Without Device). Flexible, compliant Contract Development and Manufacturing Organization (CDMO) solutions for global markets, including premix, bulk capsules, and finished dosage forms with or without device integration. Product Development (CRO)​ – Generics & Novel Products. End-to-end product development for generic and differentiated formulations, our contract research organisation (CRO) service is tailored for highly regulated markets like US and EU. Technology Transfer –  Scale-Up & Commercialisation. Seamless technology transfer from lab to market of inhalation portfolio, ensuring validated scale-up, regulatory support, […] - [Blog](https://vamsipharma.com/blog/) - [Home](https://vamsipharma.com/): Integrated Solutions for Dry Powder Inhalation Therapy – From Concept to Commercialisation CDMO & CRO Partners in Respiratory Care, Specialised in DPIs Our Expertise Inhalation Expertise Under One Roof We are not limited to one aspect of inhalation; Vamsi Pharma provides complete expertise under a single roof. Our capabilities cover Premix, bulk capsules, Dry Powder Inhalers (DPI) device–drug combination products, along with providing customized tech transfer services, enabling us to deliver versatile, end-to-end solutions. We also offer rigorous quality assurance and regulatory support to ensure compliance at every stage. Holistic Expertise, Backed By Strong Team Our strength lies in a multidisciplinary […] ## Optional - [Agent (MCP protocol)](websites-agents.hostinger.com/vamsipharma.com/mcp) [comment]: # (Generated by Hostinger Tools Plugin)